Taking into account the high prevalence of cocaine use disorder in AUD patients, it is important to note that extensive preclinical research has reported how the chemokines SDF-1 and MCP-1 promote cocaine-related behaviors in a brain region specific manner [51,52,53]. The gene discussed is CCL2; the disease is cocaine use disorder.